Article
New Evidence, New Treatments: The Impact of Clinical Trials on GlaucomaManagement
Chicago-The decision of whether to treat glaucoma or ocular hypertensionshould be a mutual one reached by both ophthalmologist and patient. Thedecision should take into account the risk of visual loss as the resultof glaucoma over the patient's lifetime and the potential treatment benefits.The risk factors that are most important in deciding whether to treat patientsinclude the level of IOP, race, age, and family history of glaucoma. KuldevSingh, MD, discussed the individualized approach to patient treatment andall factors that need to be considered.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
